Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts

被引:28
作者
Chand, Ashwini L. [1 ]
Herridge, Kerrie A. [1 ]
Howard, Tamara L. [1 ]
Simpson, Evan R. [1 ]
Clyne, Colin D. [1 ]
机构
[1] Monash Med Ctr, Prince Henrys Inst, Melbourne, Vic 3168, Australia
关键词
Aromatase; LRH-1; NR5A2; Breast cancer; ESTROGEN BIOSYNTHESIS; HOMOLOG-1; LRH-1; CANCER CELLS; CYCLIC-AMP; EXPRESSION; GENE; STEROIDOGENESIS; ACTIVATION; KINASE; TARGET;
D O I
10.1016/j.steroids.2011.02.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In postmenopausal breast cancers, the increase in aromatase expression observed in tumour associated adipose stromal cells is mediated via the upregulation of promoter II (PII) transcription. Factors such as PGE(2) which are secreted from breast carcinomas induce PII expression. The orphan nuclear receptor LRH-1 /NR5A2 is one of the critical downstream transcriptional mediators of this effect. The aim of the current study was to determine whether LRH-1 could bind directly to PII and whether the suppression of LRH-1 expression could inhibit aromatase expression in human adipose stromal fibroblasts. Chromatin immunoprecipitation demonstrated endogenous LRH-1 occupancy on PII under basal conditions and with treatment with forskolin and phorbol 1 2-myristate 13-acetate (PMA). To assess the impact of LRH-1 knockdown on FSK/PMA mediated PII expression, cells were transfected with shRNA targeted against LRH-1 (shLRH-1) and treated with forskolin and PMA. A decrease in LRH-1, PII and total aromatase mRNA transcripts was observed in 5hLRH-1 transfected cells compared to controls under basal and treatment conditions. The results of this study support the hypothesis that suppression of LRH-1 may potentially be beneficial in the tissue specific regulation of aromatase expression in post menopausal breast cancer. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:741 / 744
页数:4
相关论文
共 25 条
[1]   AROMATIZATION OF ANDROSTENEDIONE BY HUMAN ADIPOSE-TISSUE STROMAL CELLS IN MONOLAYER-CULTURE [J].
ACKERMAN, GE ;
SMITH, ME ;
MENDELSON, CR ;
MACDONALD, PC ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (02) :412-417
[2]   Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients [J].
Agarwal, VR ;
Bulun, SE ;
Leitch, M ;
Rohrich, R ;
Simpson, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :3843-3849
[3]   The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene [J].
Annicotte, JS ;
Chavey, C ;
Servant, N ;
Teyssier, J ;
Bardin, A ;
Licznar, A ;
Badia, E ;
Pujol, P ;
Vignon, F ;
Maudelonde, T ;
Lazennec, G ;
Cavailles, V ;
Fajas, L .
ONCOGENE, 2005, 24 (55) :8167-8175
[4]   Synergy between LRH-1 and β-catenin induces G1 cyclin-mediated cell proliferation [J].
Botrugno, OA ;
Fayard, E ;
Annicotte, JS ;
Haby, C ;
Brennan, T ;
Wendling, O ;
Tanaka, T ;
Kodama, T ;
Thomas, W ;
Auwerx, J ;
Schoonjans, K .
MOLECULAR CELL, 2004, 15 (04) :499-509
[5]   Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells [J].
Bouchard, MF ;
Taniguchi, H ;
Viger, RS .
ENDOCRINOLOGY, 2005, 146 (11) :4905-4916
[6]   Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women [J].
Brown, Kristy A. ;
McInnes, Kerry J. ;
Hunger, Nicole I. ;
Oakhiil, Jonathan S. ;
Steinberg, Gregory R. ;
Simpson, Evan R. .
CANCER RESEARCH, 2009, 69 (13) :5392-5399
[7]   REGULATION OF AROMATASE EXPRESSION IN HUMAN TISSUES [J].
BULUN, SE ;
SIMPSON, ER .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) :19-29
[8]   The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion [J].
Chand, A. L. ;
Herridge, K. A. ;
Thompson, E. W. ;
Clyne, C. D. .
ENDOCRINE-RELATED CANCER, 2010, 17 (04) :965-975
[9]   Aromatase expression is increased in BRCA1 mutation carriers [J].
Chand, Ashwini L. ;
Thorne, Heather ;
Simpson, Evan R. ;
Clyne, Colin D. .
BMC CANCER, 2009, 9
[10]   Prostaglandin E2 induces breast cancer-related aromatase promoters via activation of p38 and c-jun NH2-Terminal kinase in adipose fibroblasts [J].
Chen, Dong ;
Reierstad, Scott ;
Lin, Zhihong ;
Lu, Meiling ;
Brooks, Chris ;
Li, Newton ;
Innes, Jon ;
Bulun, Serdar E. .
CANCER RESEARCH, 2007, 67 (18) :8914-8922